RG
Publications
229
Views
91,026
Downloads
5,909
Supervised works
19
Items per page
1 - 229 of 229
Title Published in Access level OA Policy Year Views Downloads
Ocular Biodistribution of Spironolactone after a Single Intravitreal Injection of a Biodegradable Sustained-Release Polymer in RatsMolecular Pharmaceutics
accessLevelRestricted
2020 307 2
Self-assembled mPEG-hexPLA polymeric nanocarriers for the targeted cutaneous delivery of imiquimodEuropean Journal of Pharmaceutics and Biopharmaceutics
accessLevelRestricted
2019 321 2
Poly-Lactic Acid-Based Biopolymer Formulations Are Safe for Sustained Intratympanic Dexamethasone DeliveryOtology & Neurotology
accessLevelRestricted
2019 388 0
Effect of implantation site on outcome of tissue-engineered vascular graftsEuropean Journal of Pharmaceutics and Biopharmaceutics
accessLevelRestricted
2019 420 1
A novel biocompatible hyaluronic acid-chitosan hybrid hydrogel for osteoarthrosis therapyInternational journal of pharmaceutics
accessLevelRestricted
2015 884 2
Controlled drug release from melt-extrudates through processing parameters: A chemometric approachInternational journal of pharmaceutics
accessLevelRestricted
2015 648 0
Strategies for formulating and delivering poorly water-soluble drugsJournal of drug delivery science and technology
accessLevelRestricted
2015 830 1
New prostaglandin analog formulation for glaucoma treatment containing cyclodextrins for improved stability, solubility and ocular toleranceEuropean journal of pharmaceutics and biopharmaceutics
accessLevelRestricted
2015 679 1
Coupling ultra high-pressure liquid chromatography with mass spectrometry: Constraints and possible applicationsJournal of chromatography
accessLevelRestricted
2013 649 5
Plasma treatment for improving cell biocompatibility of a biodegradable polymer scaffold for vascular graft applicationsEuropean journal of pharmaceutics and biopharmaceutics
accessLevelRestricted
2013 677 2
In vivo distribution and ex vivo permeation of cyclosporine A prodrug aqueous formulations for ocular applicationJournal of controlled release
accessLevelRestricted
2013 620 0
In vivo biocompatibility, sustained-release and stability of triptorelin formulations based on a liquid, degradable polymerJournal of controlled release
accessLevelRestricted
2013 660 1
In vivo characterisation of a novel water-soluble Cyclosporine A prodrug for the treatment of dry eye diseaseEuropean journal of pharmaceutics and biopharmaceutics
accessLevelRestricted
2012 698 0
Novel self-associative and multiphasic nanostructured soft carriers based on amphiphilic hyaluronic acid derivativesCarbohydrate Polymers
accessLevelRestricted
2012 446 0
Long term performance of polycaprolactone vascular grafts in a rat abdominal aorta replacement modelBiomaterials
accessLevelRestricted
2012 766 0
Advantages of bilayered vascular grafts for surgical applicability and tissue regenerationActa biomaterialia
accessLevelRestricted
2012 698 0
Injectable rhBMP-2-loaded chitosan hydrogel composite: osteoinduction at ectopic site and in segmental long bone defectJournal of biomedical materials research. Part A
accessLevelRestricted
2011 722 0
Novel micelle formulations to increase cutaneous bioavailability of azole antifungalsJournal of controlled release
accessLevelRestricted
2011 632 3
The effects of carrier nature and pH on rhBMP-2-induced ectopic bone formationJournal of controlled release
accessLevelRestricted
2010 640 0
Benefit of anti-HER2-coated paclitaxel-loaded immuno-nanoparticles in the treatment of disseminated ovarian cancer: Therapeutic efficacy and biodistribution in miceJournal of controlled release
accessLevelRestricted
2010 726 3
Interaction of biodegradable nanoparticles with intestinal cells: the effect of surface hydrophilicityInternational Journal of Pharmaceutics
accessLevelRestricted
2010 415 1
Physical instability, aggregation and conformational changes of recombinant human bone morphogenetic protein-2 (rhBMP-2)International journal of pharmaceutics
accessLevelRestricted
2010 673 0
Paclitaxel-eluting biodegradable synthetic vascular prostheses: a step towards reduction of neointima formation?Circulation
accessLevelRestricted
2009 636 1
Pharmacokinetics and posterior segment biodistribution of ESBA105, an anti-TNF-alpha single-chain antibody, upon topical administration to the rabbit eyeInvestigative ophthalmology & visual science
accessLevelRestricted
2009 579 0
Thrombin-sensitive photodynamic agents: a novel strategy for selective synovectomy in rheumatoid arthritisJournal of controlled release
accessLevelPrivate
2009 710 0
Novel thermosensitive chitosan hydrogels: in vivo evaluationJournal of biomedical materials research. Part A
accessLevelRestricted
2009 689 3
Quenching-induced deactivation of photosensitizer by nanoencapsulation to improve phototherapy of cancerJournal of Drug Targeting
accessLevelRestricted
2009 439 0
Benchtop-magnetic resonance imaging (BT-MRI) characterization of push-pull osmotic controlled release systemsJournal of controlled release
accessLevelRestricted
2009 623 0
A high throughput protein formulation platform: case study of salmon calcitoninPharmaceutical research
accessLevelPublic
2009 646 547
Factorial design optimization and in vivo feasibility of poly(epsilon-caprolactone)-micro- and nanofiber-based small diameter vascular graftsJournal of biomedical materials research. Part A
accessLevelPrivate
2009 580 0
Benefits of nanoencapsulation for the hypercin-mediated photodetection of ovarian micrometastasesEuropean journal of pharmaceutics and biopharmaceutics
accessLevelRestricted
2009 666 0
Localization and quantification of biodegradable particles in an intestinal cell model: the influence of particle sizeEuropean journal of pharmaceutical sciences
accessLevelRestricted
2009 650 0
Screening of nanoparticulate delivery systems for the photodetection of cancer in a simple and cost-effective modelNanomedicine
accessLevelPrivate
2009 643 0
Toward the understanding of the photodynamic activity of m-THPP encapsulated in PLGA nanoparticles: correlation between nanoparticle properties and in vivo activityJournal of Drug Targeting
accessLevelRestricted
2009 400 1
Nanomedicines for active targeting: physico-chemical characterization of paclitaxel-loaded anti-HER2 immunonanoparticles and in vitro functional studies on target cellsEuropean journal of pharmaceutical sciences
accessLevelRestricted
2009 598 0
A novel thermoresponsive hydrogel based on chitosanEuropean journal of pharmaceutics and biopharmaceutics
accessLevelRestricted
2008 739 1
Assessment of tailor-made HPMC-based matrix minitablets comprising a weakly basic drug compoundDrug development and industrial pharmacy
2008 596 0
High throughput methods to characterize protein permeation and releaseInternational journal of pharmaceutics
accessLevelRestricted
2008 832 3
Colloidal Drug Delivery Systems - Recent Advances With Polymeric MicellesChimia
accessLevelRestricted
2008 927 38
Permeation enhancer effect of chitosan and chitosan derivatives: comparison of formulations as soluble polymers and nanoparticulate systems on insulin absorption in Caco-2 cellsEuropean Journal of Pharmaceutics and Biopharmaceutics
accessLevelRestricted
2008 503 1
In vivo photodynamic activity of photosensitizer-loaded nanoparticles : formulation properties, administration parameters and biological issues involved in PDT outcomeEuropean journal of pharmaceutics and biopharmaceutics
accessLevelRestricted
2008 683 1
A biodegradable drug delivery system for the treatment of postoperative inflammationInternational journal of pharmaceutics
accessLevelRestricted
2008 512 1
Controlled delivery of 5-chlorouracil using poly(ortho esters) in filtering surgery for glaucomaInvestigative ophthalmology & visual science
accessLevelRestricted
2008 678 0
Effects on gram-negative and gram-positive bacteria mediated by 5-aminolevulinic acid and 5-aminolevulinic acid derivativesAntimicrobial agents and chemotherapy
accessLevelRestricted
2008 744 0
Thermosetting gel for the delivery of 5-aminolevulinic acid esters to the cervixJournal of pharmaceutical sciences
accessLevelRestricted
2008 643 0
Cellular Uptake of PEO Surface-Modified Nanoparticles: Evaluation of Nanoparticles Made of PLA : PEO Diblock and Triblock CopolymersJournal of drug targeting
accessLevelRestricted
2008 40 0
Degradation and healing characteristics of small-diameter poly(epsilon-caprolactone) vascular grafts in the rat systemic arterial circulationCirculation
accessLevelRestricted
2008 627 0
Nanoparticles for drug delivery : the need for precision in reporting particle size parametersEuropean journal of pharmaceutics and biopharmaceutics
accessLevelRestricted
2008 669 2
Differential tumor cell targeting of anti-HER2 (Herceptin) and anti-CD20 (Mabthera) coupled nanoparticlesInternational journal of pharmaceutics
accessLevelRestricted
2007 650 0
Fluorescent biodegradable PLGA particles with narrow size distributions: preparation by means of selective centrifugationInternational journal of pharmaceutics
accessLevelRestricted
2007 694 7
Biological conversion of a water-soluble prodrug of cyclosporine AEuropean journal of pharmaceutics and biopharmaceutics
accessLevelRestricted
2007 634 8
Tailoring protease-sensitive photodynamic agents to specific disease-associated enzymesBioconjugate chemistry
accessLevelRestricted
2007 642 0
Poly(hexyl-substituted lactides): novel injectable hydrophobic drug delivery systemsJournal of biomedical materials research. Part A
accessLevelRestricted
2007 666 2
Polymeric photosensitizer prodrugs for photodynamic therapyPhotochemistry and photobiology
accessLevelPrivate
2007 652 0
NIR analysis of cellulose and lactose—Application to ecstasy tablet analysisForensic science international
accessLevelRestricted
2007 933 1
The chick embryo and its chorioallantoic membrane (CAM) for the in vivo evaluation of drug delivery systemsAdvanced drug delivery reviews
accessLevelRestricted
2007 666 2
Synergies of VEGF inhibition and photodynamic therapy in the treatment of age-related macular degenerationInvestigative ophthalmology & visual science
accessLevelRestricted
2007 535 0
Clinical evaluation of bioadhesive hydrogels for topical delivery of hexylaminolevulinate to Barrett's esophagusJournal of controlled release
accessLevelPrivate
2007 675 0
Characterization of protein aggregation: the case of a therapeutic immunoglobulinBiochimica et biophysica acta
accessLevelRestricted
2007 635 0
Detection and characterization of protein aggregates by fluorescence microscopyInternational journal of pharmaceutics
accessLevelRestricted
2007 636 0
High throughput screening of protein formulation stability: practical considerationsEuropean journal of pharmaceutics and biopharmaceutics
accessLevelRestricted
2007 642 0
Evaluation of a topical cyclosporine A prodrug on corneal graft rejection in ratsMolecular vision
accessLevelPublic
2006 72 57
Preparation of surfactant-free nanoparticles of methacrylic acid copolymers used for film coatingAAPS PharmSciTech
accessLevelPublic
2006 577 196
Biodegradable nanoparticles for direct or two-step tumor immunotargetingBioconjugate chemistry
accessLevelRestricted
2006 499 0
Nanoparticulate drug carriers based on hybrid poly(D,L-lactide-co-glycolide)-dendron structuresBiomaterials
accessLevelRestricted
2006 504 1
Hypericin-loaded nanoparticles for the photodynamic treatment of ovarian cancerInternational journal of pharmaceutics
accessLevelRestricted
2006 544 1
Novel polymeric micelles for hydrophobic drug delivery based on biodegradable poly(hexyl-substituted lactides)International journal of pharmaceutics
accessLevelRestricted
2006 562 4
Microenvironmental pH and microviscosity inside pH-controlled matrix tablets: An EPR imaging studyJournal of controlled release
accessLevelRestricted
2006 171 0
An Open Pharmacokinetic Study of Hexylaminolevulinate-Induced Photodiagnosis after Intravesical AdministrationDrugs in R&D
accessLevelPublic
2006 113 99
Strategies for the design of hydrophilic matrix tablets with controlled microenvironmental pHInternational journal of pharmaceutics
accessLevelRestricted
2006 522 1
Intraocular implants for extended drug delivery: therapeutic applicationsAdvanced drug delivery reviews
accessLevelRestricted
2006 617 1
Where disease pathogenesis meets protein formulation: renal deposition of immunoglobulin aggregatesEuropean journal of pharmaceutics and biopharmaceutics
accessLevelRestricted
2006 375 1
Biodegradable scleral implants as new triamcinolone acetonide delivery systemsInternational journal of pharmaceutics
accessLevelRestricted
2006 476 1
5‐Aminolevulinic Acid Derivatives in Photomedicine: Characteristics, Application and PerspectivesPhotochemistry and photobiology
accessLevelRestricted
2006 82 0
In vitro and in vivo activities of verteporfin-loaded nanoparticlesJournal of Controlled Release
accessLevelRestricted
2005 171 0
Coupling Methods to Obtain Ligand-Targeted Liposomes and NanoparticlesMicroencapsulation : methods and industrial applications
accessLevelRestricted
2005 60 0
Conversion of cyclosporine A prodrugs in human tears vs rabbits tearsEuropean journal of pharmaceutics and biopharmaceutics
accessLevelRestricted
2005 457 0
Polymeric Nanoparticles for Drug Delivery to the Posterior Segment of the EyeChimia
accessLevelRestricted
2005 451 0
A water-soluble prodrug of cyclosporine A for ocular application: A stability studyEuropean journal of pharmaceutical sciences
accessLevelPublic
2005 796 652
Trans-scleral diffusion of triamcinolone acetonideCurrent eye research
accessLevelRestricted
2005 529 1
The use of drug-loaded nanoparticles in cancer chemotherapyMicroencapsulation : Methods and Industrial Applications
accessLevelRestricted
2005 53 0
Pseudo-thermosetting chitosan hydrogels for biomedical applicationInternational journal of pharmaceutics
accessLevelRestricted
2005 532 1
Ecole de Pharmacie Geneve-Lausanne: A novel center of excellence in GenevaChimia
2005 383 0
A novel water-soluble cyclosporine A prodrug: ocular tolerance and in vivo kineticsInternational journal of pharmaceutics
accessLevelRestricted
2005 532 1
Synthesis and Ring-Opening Polymerization of New Monoalkyl-Substituted LactidesJournal of polymer science. Part A, Polymer chemistry
accessLevelRestricted
2004 241 0
Improved photodynamic activity of porphyrin loaded into nanoparticles: an in vivo evaluation using chick embryosInternational journal of pharmaceutics
accessLevelRestricted
2004 506 1
Biodegradable PLGA microparticles for sustained release of a new GnRH antagonist: part II. In vivo performanceEuropean journal of pharmaceutics and biopharmaceutics
accessLevelRestricted
2004 528 0
New surface-active polymers for ophthalmic formulations: evaluation of ocular toleranceEuropean journal of pharmaceutics and biopharmaceutics
accessLevelRestricted
2004 489 3
Structure and interactions in chitosan hydrogels formed by complexation or aggregation for biomedical applicationsEuropean journal of pharmaceutics and biopharmaceutics
accessLevelRestricted
2004 567 1
Poly(lactic acid) nanoparticles labeled with biologically active Neutravidin for active targetingEuropean journal of pharmaceutics and biopharmaceutics
accessLevelRestricted
2004 439 4
Structure and interactions in covalently and ionically crosslinked chitosan hydrogels for biomedical applicationsEuropean journal of pharmaceutics and biopharmaceutics
accessLevelRestricted
2004 500 1
Current Methods for Attaching Targeting Ligands to Liposomes and NanoparticlesJournal of Pharmaceutical Sciences
accessLevelRestricted
2004 164 0
Ocular biocompatibility of a poly(ortho ester) characterized by autocatalyzed degradationJournal of biomedical materials research. Part A
accessLevelRestricted
2003 176 0
Ocular drug delivery targeting the retina and retinal pigment epithelium using polylactide nanoparticlesInvestigative Ophthalmology & Visual Science
accessLevelPublic
2003 465 149
Preparation and characterization of sterile sub-200 nm meso-tetra(4-hydroxylphenyl)porphyrin-loaded nanoparticles for photodynamic therapyEuropean journal of pharmaceutics and biopharmaceutics
accessLevelRestricted
2003 639 0
Bioadhesive Ophthalmic Drug Inserts (BODI)Modified-release drug delivery technology
accessLevelPublic
2003 93 114
In Vitro Monitoring of Poly(ortho ester) Degradation by Electron Paramagnetic Resonance ImagingMacromolecules
accessLevelRestricted
2003 750 0
Biodegradable microparticles for sustained release of a new GnRH antagonist - part I: Screening commercial PLGA and formulation technologiesEuropean journal of pharmaceutics and biopharmaceutics
accessLevelRestricted
2003 464 1
Encapsulation of p-THPP into Nanoparticles: Cellular Uptake, Subcellular Localization and Effect of Serum on Photodynamic ActivityPhotochemistry and photobiology
accessLevelRestricted
2003 60 0
Bioerodible injectable poly(ortho ester) for tetracycline controlled delivery to periodontal pockets: Preliminary trial in humansAAPS PharmSci
accessLevelRestricted
2002 561 0
Development of poly(ortho esters) and their application for bovine serum albumin and bupivacaine deliveryJournal of controlled release
accessLevelRestricted
2002 506 0
Ocular tolerance of absorption enhancers in ophthalmic preparationsAAPS PharmSci
accessLevelRestricted
2002 447 1
Preparation and characterization of sterile and freeze-dried sub-200 nm nanoparticlesInternational journal of pharmaceutics
accessLevelRestricted
2002 458 2
State of the art in the delivery of photosensitizers for photodynamic therapyJournal of photochemistry and photobiology. B, Biology
accessLevelRestricted
2002 63 0
Evaluation of a novel biomaterial in the suprachoroidal space of the rabbit eyeInvestigative ophthalmology and visual science
accessLevelPublic
2002 192 106
Delivery of antibiotics to the eye using a positively charged polysaccharide as vehicleAAPS PharmSci
accessLevelRestricted
2001 494 0
Therapeutic applications of viscous and injectable poly(ortho esters)Advanced drug delivery reviews
accessLevelRestricted
2001 505 1
Inhibition of HIV-1 in Cell Culture by Oligonucleotide-Loaded NanoparticlesPharmaceutical research
accessLevelPublic
2001 49 96
Fluorescence correlation spectroscopy for the characterisation of drug delivery systemsBiological chemistry
accessLevelRestricted
2001 488 0
Challenges of Intraocular Drug DeliveryEuropean pharmaceutical review
accessLevelPublic
2001 97 12
Influence of hot-melt extrusion and compression molding on polymer structure organization, investigated by differential scanning calorimetryJournal of Applied Polymer Science
accessLevelRestricted
2001 342 0
Release of BSA from poly(ortho ester) extruded thin strandsJournal of Controlled Release
accessLevelRestricted
2001 249 0
A new poly(ortho ester)-based drug delivery system as an adjunct treatment in filtering surgeryInvestigative Ophthalmology & Visual Science
accessLevelPublic
2001 302 107
Treatment of Intralocular Diseases with Poly(ortho ester)-Based Drug Delivery SystemsMacromolecular symposia
accessLevelRestricted
2001 108 0
pH-Dependent dissolving nano- and microparticles for improved peroral delivery of a highly lipophilic compound in dogsAAPS PharmSci
accessLevelRestricted
2001 536 0
Tamoxifen encapsulation within polyethylene glycol-coated nanospheres. A new antiestrogen formulationInternational journal of pharmaceutics
accessLevelRestricted
2001 465 1
Optimization of a novel bioerodible device based on auto-catalyzed poly(ortho esters) for controlled delivery of tetracycline to periodontal pocketBiomaterials
accessLevelRestricted
2001 464 1
Protein Release from Poly(ortho ester) Extruded RodsMacromolecular symposia
accessLevelRestricted
2001 74 0
Development of poly(ortho esters)Drug delivery systems & sciences
accessLevelRestricted
2001 401 1
Polymeric systems for ophthalmic drug deliveryPolymeric Biomaterials
accessLevelRestricted
2001 55 0
Comparison of two methods of encapsulation of an oligonucleotide into poly(D,L-lactic acid) particlesInternational journal of pharmaceutics
accessLevelRestricted
2001 529 1
Poly(ortho esters) - A Versatile Drug Delivery SystemBiomaterials and Drug Delivery toward New Mellenium
accessLevelRestricted
2000 418 0
Near Infrared with Principal Component Analysis as a Novel Analytical Approach for Nanoparticle TechnologyPharmaceutical research
accessLevelPublic
2000 58 120
Poly (ortho esters) implants for the sustained delivery of a protein factors influencing the release behaviour of BSA in vitroThe 27th International Symposium on Controlled Release of Bioactive Materials and the Third Consumer and Diversified Products Conference
accessLevelPublic
2000 48 46
Oral bioavailability of a poorly water soluble HIV-1 protease inhibitor incorporated into pH-sensitive particles: effect of the particle size and nutritional stateJournal of controlled release
accessLevelRestricted
2000 187 0
Poly(ortho esters) - their development and some recent applicationsEuropean journal of pharmaceutics and biopharmaceutics
accessLevelRestricted
2000 522 1
Local delivery of antimicrobial agents for the treatment of periodontal diseasesEuropean journal of pharmaceutics and biopharmaceutics
accessLevelRestricted
2000 426 1
Improved biocompatibility of a viscous bioerodible poly(ortho ester) by controlling the environmental pH during degradationBiomaterials
accessLevelRestricted
2000 541 2
A poly(ortho ester) designed for combined ocular delivery of dexamethasone sodium phosphate and 5-fluorouracil: subconjunctival tolerance and in vitro releaseEuropean journal of pharmaceutics and biopharmaceutics
accessLevelRestricted
2000 641 0
Application of in vivo confocal microscopy to the objective evaluation of ocular irritation induced by surfactantsInternational journal of pharmaceutics
accessLevelRestricted
2000 448 1
A novel analytical approach for the characterization of poly(MePegcyanoacrylate - co - hexadecylcyanoacrylate) nanoparticlesThe 27th International Symposium on Controlled Release of Bioactive Materials and the Third Consumer and Diversified Products Conference
accessLevelPublic
2000 48 27
Freeze-Drying and Lyopreservation of Diblock and Triblock Poly(Lactic Acid)–Poly(Ethylene Oxide) (PLA–PEO) Copolymer NanoparticlesPharmaceutical development and technology
accessLevelRestricted
2000 61 0
Chitosan as Tear Substitute: A Wetting Agent Endowed with Antimicrobial EfficacyJournal of Ocular Pharmacology and Therapeutics
accessLevelRestricted
2000 116 0
Salivary fluoride concentrations following applications of bioadhesive tablets and mouthrinsesEuropean journal of pharmaceutics and biopharmaceutics
accessLevelRestricted
2000 486 1
Formation of peptide impurities in polyester matrices during implant manufacturingEuropean journal of pharmaceutics and biopharmaceutics
accessLevelRestricted
2000 592 0
Formulation and technology aspects of conrolled drug delivery in animalsPharmaceutical science & technology today
accessLevelRestricted
2000 75 0
Design and development of controlled release veterinary drug delivery systems to the eyeControlled Release Veterinary Drug Delivery
accessLevelRestricted
2000 133 0
Freeze-drying of PLA-PEO nanoparticles : from basic principles to rational optimizationCRS proceedings
accessLevelPublic
1999 220 27
Production of biodegradable implants for the sustained release of pharmaceuticalsAsian Conference and Exhibition of Controlled Release
accessLevelRestricted
1999 417 1
Evaluation of the local and systemic inflammatory responses induced by the subcutaneous injection of different biopolymersCRS proceedings
accessLevelPublic
1999 47 29
Cellular uptake of nanoparticles made of poly(lactic acid), poly(ethylene oxide) diblock and triblock copolymersCRS proceedings
accessLevelPublic
1999 49 24
Topical use of chitosan in ophthalmology: tolerance assessment and evaluation of precorneal retentionInternational journal of pharmaceutics
accessLevelRestricted
1999 519 1
Hydrolysis and Erosion Studies of Autocatalyzed Poly(ortho esters) Containing Lactoyl−Lactyl Acid DimersMacromolecules
accessLevelRestricted
1999 147 0
How to avoid the formation of peptide impurities during manufacturing of implants by melt-extrusion ?CRS proceedings
accessLevelPublic
1999 47 30
A viscous bioerodible poly(ortho ester) as a new biomaterial for intraocular applicationJournal of biomedical materials research
accessLevelPublic
1999 159 156
Erosion, properties and drug release from a new family of poly(ortho esters)Proceedings of the 26th International Symposium on Controlled Release of Bioactive Materials and the Second Conference on Consumer and Diversified Products
accessLevelPublic
1999 39 12
Poly(ortho esters)Encyclopedia of controlled drug delivery
accessLevelRestricted
1999 109 0
Formulation and Lyoprotection of Poly(Lactic Acid-Co-Ethylene Oxide) Nanoparticles: Influence on Physical Stability and In Vitro Cell UptakePharmaceutical research
accessLevelPublic
1999 43 99
Biodegradable implantsAsian Conference and Exhibition of Controlled Release
accessLevelPublic
1999 391 49
Evaluation of poly(ortho ester) for intraocular application in rabbits: biocompatibility assessment and in vitro degradationCRS proceedings
accessLevelPublic
1999 54 95
Highly loaded nanoparticulate carrier using an hydrophobic antisense oligonucleotide complexEuropean journal of pharmaceutical sciences
accessLevelRestricted
1999 507 0
Poly(ortho ester): a new biocompatible intraocular drug delivery systemAsian Conference and Exhibition of Controlled Release
accessLevelPublic
1999 79 16
Ocular tolerance of preservatives on the murine corneaEuropean journal of pharmaceutics and biopharmaceutics
accessLevelRestricted
1999 412 1
Synthesis and characterization of self-catalyzed poly(ortho-esters) based on decanediol and decanediol-lactateJournal of biomaterials science. Polymer ed
accessLevelRestricted
1999 132 0
Stability studies of a somatostatin analogue in biodegradable implantsInternational journal of pharmaceutics
accessLevelRestricted
1999 433 1
Mucosal drug delivery, ocularEncyclopedia of controlled drug delivery
accessLevelRestricted
1999 140 0
Injection-molding versus extrusion as manufacturing technique for the preparation of biodegradable implantsEuropean journal of pharmaceutics and biopharmaceutics
accessLevelRestricted
1999 543 3
Uptake of oligonucleotide-loaded nanoparticles in prostatic cancer cells and their intracellular localizationEuropean journal of pharmaceutics and biopharmaceutics
accessLevelRestricted
1999 453 2
Mucosal drug delivery, intravitrealEncyclopedia of controlled drug delivery
accessLevelRestricted
1999 149 0
Gamma scintigraphy as tool for the evaluation of precorneal residence time: influence of the methodologyCRS proceedings
accessLevelPublic
1999 41 37
NanoparticlesEncyclopedia of controlled drug delivery
accessLevelRestricted
1999 193 0
Protein delivery from extruded poly(ortho esters)Asian Conference and Exhibition of Controlled Release
accessLevelPublic
1999 391 45
Application of fluorescence correlation spectroscopy for the characterisation of drug delivery systemsCRS proceedings
accessLevelPublic
1999 46 67
Concomitant and controlled release of dexamethasone and 5-fluorouracil from poly(ortho ester)International journal of pharmaceutics
accessLevelRestricted
1999 579 0
Synthesis and characterization of self-catalyzed poly(ortho ester)Biomaterials
accessLevelRestricted
1998 621 0
Topical use of chitosan in ophthalmology : tolerance assessment by confocal microscopy and precorneal retention evaluation by gamma scintigraphy2nd World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology
accessLevelRestricted
1998 511 2
Synthesis and characterization of new bioerodible polymers designed for controlled drug release applications2nd World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology
accessLevelRestricted
1998 304 1
pH-Sensitive microparticles as oral delivery systems for antiinfective agents of poor water solubility2nd World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology
accessLevelRestricted
1998 504 1
In vitro drug release from self-catalyzed poly(ortho ester): Case study of 5-fluorouracilJournal of controlled release
accessLevelRestricted
1998 190 0
Injection-moulding versus extrusion for the preparation of long-acting biodegradable implants2nd World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology
accessLevelRestricted
1998 618 1
Current status in oral fluoride pharmacokinetics and implications for the prophylaxis against dental cariesEuropean journal of pharmaceutics and biopharmaceutics
accessLevelRestricted
1998 476 1
Biodegradable polymers for the controlled release of ocular drugsProgress in polymer science
accessLevelRestricted
1998 49 0
Chitosan: a unique polysaccharide for drug deliveryDrug development and industrial pharmacy
accessLevelRestricted
1998 553 0
A biodegradable polymer designed for concomitant delivery of dexamethasone and 5-fluorouracil to the eye2nd World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology
accessLevelRestricted
1998 453 1
Optimized release of dexamethasone and gentamicin from a soluble ocular insert for the treatment of external ophthalmic infectionsJournal of controlled release
accessLevelRestricted
1998 645 0
Clinical evaluation of bioadhesive ophthalmic drug inserts (BODI) containing gentamicin for the treatment of external ophthalmic infections2nd World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology
accessLevelRestricted
1998 430 1
Development and evaluation in vivo of a long-term delivery system for vapreotide, a somatostatin analogueJournal of controlled release
accessLevelRestricted
1998 206 0
Polymeric nano- and microparticles for the oral delivery of peptides and peptidomimeticsAdvanced drug delivery reviews
accessLevelRestricted
1998 443 0
Poly (D,L-lactic acid) nanoparticles as phosphorothioate oligonucleotide carriers in U937 cells2nd World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology
accessLevelRestricted
1998 440 1
Evaluation of Soluble Bioadhesive Ophthalmic Drug Inserts (BODI®) for Prolonged Release of Gentamicin: Lachrymal Pharmacokinetics and Ocular ToleranceJournal of Ocular Pharmacology and Therapeutics
accessLevelRestricted
1998 123 0
Bioerodible Polymers for Ocular Drug DeliveryCritical reviews in therapeutic drug carrier systems
accessLevelRestricted
1998 148 0
Influence of irradiation sterilization on a semi-solid poly(ortho ester)International journal of pharmaceutics
accessLevelRestricted
1998 545 0
Therapeutic applications of retinoids in ophthalmologyInternational journal of pharmaceutics
accessLevelRestricted
1997 432 2
Synthesis and analysis of viscous poly (ortho-ester) analogs for controlled drug releaseInternational journal of pharmaceutics
accessLevelRestricted
1997 503 1
Analysis of the influence of polymer characteristics and core loading on the in vivo release of a somatostatin analogueEuropean journal of pharmaceutical sciences
accessLevelRestricted
1997 473 0
Prophylaxis of caries : in vivo evaluation of various oral fluoride containing preparations designed to optimize salivary concentrationsProceedings of the 24th International Symposium on Controlled Release of Bioactive Materials
accessLevelRestricted
1997 58 0
Influence of Irradiation Sterilization on Polymers Used as Drug Carriers : A ReviewDrug development and industrial pharmacy
accessLevelRestricted
1997 552 1
Determination of dexamethasone in tears by capillary electrophoresisJournal of chromatography. B, Biomedical sciences and applications
1997 506 0
Confocal Microscopy as a Tool for the Investigation of the Anterior Part of the EyeJournal of Ocular Pharmacology and Therapeutics
accessLevelRestricted
1997 114 0
Ocular drug delivery in veterinary medicineAdvanced drug delivery reviews
accessLevelRestricted
1997 533 0
PLA-PEG nanoparticles: preparation and cell interaction studiesProceedings of the 24th International Symposium on Controlled Release of Bioactive Materials
accessLevelPublic
1997 40 23
In vivo evaluation of hydrophilic and hydrophobic mucoadhesive semi-solid formulations containing sucralfate and lidocaine for intraoral useEuropean journal of pharmaceutics and biopharmaceutics
accessLevelRestricted
1997 436 1
Synthesis and characterization of ointment-like self-catalyzed poly(ortho ester)Proceedings of the 24th International Symposium on Controlled Release of Bioactive Materials
accessLevelPublic
1997 48 136
New generation of poly(ortho esters): synthesis, characterization, kinetics, sterilization and biocompatibilityJournal of controlled release
accessLevelRestricted
1997 268 0
Controlled and/or prolonged parental delivery of peptides from the hypothalmic pituitary axisEuropean journal of pharmaceutics and biopharmaceutics
accessLevelRestricted
1997 196 0
Chemical and physical parameters of tears relevant for the design of ocular drug delivery formulationsPharmaceutica Acta Helvetiae
accessLevelRestricted
1997 46 0
Combined release of dexamethasone and gentamicin from an ocular insert for treatment of external ophthalmic infectionsProceedings of the 24th International Symposium on Controlled Release of Bioactive Materials
accessLevelPublic
1997 73 82
Development of a long-term delivery system for RC-160, a somatostatin analogProceedings of the 24th International Symposium on Controlled Release of Bioactive Materials
accessLevelPublic
1997 41 28
Uptake of oligonucleotide loaded nanoparticles in prostatic cancer cells and their intracellular localizationProceedings of the 24th International Symposium on Controlled Release of Bioactive Materials
accessLevelPublic
1997 90 72
Improved biocompatibility of a viscous bioerodable poly(orthoester) by controlling the environmental pHProceedings of the 24th International Symposium on Controlled Release of Bioactive Materials
accessLevelPublic
1997 36 94
Kinetics of blood component adsorption on poly(D,L-lactic acid) nanoparticles: evidence of complement C3 component involvementJournal of biomedical materials research
accessLevelRestricted
1997 113 0
Formulation and evaluation of zinc-phthalocyanine loaded poly(D,L-lactic acid) nanoparticlesActa pharmaceutica
accessLevelPublic
1996 385 105
pH-sensitive nanoparticles: an effective means to improve the oral delivery of HIV-1 protease inhibitors in dogsPharmaceutical research
accessLevelPublic
1996 40 34
Basis for Dosing Time-Dependent Changes in the Ocular and Systemic Absorption of Topically Applied TimololJournal of Ocular Pharmacology and Therapeutics
accessLevelRestricted
1996 119 0
Development of a Novel Soluble Ophthalmic Insert: Evaluation of Ocular Tolerance in RabbitsEuropean journal of pharmaceutics and biopharmaceutics
accessLevelPublic
1996 182 55
Gamma Scintigraphic Comparison of Eyedrops Containing Pilocarpine in Healthy VolunteersJournal of Ocular Pharmacology and Therapeutics
accessLevelRestricted
1996 106 0
Biomaterials in Ophthalmic Drug DeliveryEuropean journal of pharmaceutics and biopharmaceutics
accessLevelPublic
1996 501 88
The Use of Drug-Loaded Nanoparticles in Cancer ChemotherapyMicroencapsulation : methods and industrial applications
accessLevelRestricted
1996 43 0
Mucoadhesive Semi-Solid Formulations for Intraoral Use Containing SucralfateEuropean journal of pharmaceutics and biopharmaceutics
accessLevelPublic
1996 280 162
Biodegradable nanoparticles — From sustained release formulations to improved site specific drug deliveryJournal of controlled release
accessLevelRestricted
1996 85 0
Purity and stability assessment of a semi-solid poly(ortho ester) used in drug delivery systemsBiomaterials
accessLevelRestricted
1996 503 2
Ocular availability of gentamicin in small animals after topical administration of a conventional eye drop solution and a novel long acting bioadhesive ophthalmic drug insertPharmaceutical research
accessLevelPublic
1995 48 197
Patent Literature Review of Ophthalmic InsertsDrug development and industrial pharmacy
accessLevelRestricted
1995 526 2
The use of acidic and basic excipients in the release of 5-fluorouracil and mitomycin C from a semi-solid bioerodible poly(ortho ester)Journal of controlled release
accessLevelRestricted
1995 78 0
Use of Insoluble Biodegradable Polymers in Ophthalmic Systems for the Sustained Release of DrugsEuropean journal of pharmaceutics and biopharmaceutics
accessLevelPublic
1995 300 193
Long-acting soluble bioadhesive ophthalmic drug insert (BODI) containing gentamicin for veterinary use: optimization and clinical investigationJournal of controlled release
accessLevelRestricted
1995 45 0
Topical semi-solid drug delivery: kinetics and tolerance of ophthalmic hydrogelsAdvanced drug delivery reviews
accessLevelRestricted
1995 624 0
New Approach for the Preparation of Nanoparticles by an Emulsification-Diffusion MethodEuropean journal of pharmaceutics and biopharmaceutics
accessLevelPublic
1995 643 1,319
PEG-coated Poly(lactic acid) Nanoparticles for the Delivery of Hexadecafluoro Zinc Phthalocyanine to EMT-6 Mouse Mammary TumoursJournal of Pharmacy and Pharmacology
accessLevelRestricted
1995 143 0
An investigation on the role of plasma and serum opsonins on the internalization of biodegradable poly(D,L-lactic acid) nanoparticles by human monocytesLife sciences
accessLevelRestricted
1995 138 1
Pharmacokinetics of a Novel HIV-1 Protease Inhibitor Incorporated into Biodegradable or Enteric Nanoparticles following Intravenous and Oral Administration to MiceJournal of Pharmaceutical Sciences
accessLevelRestricted
1995 110 0
Gamma sterilization of a semi-solid poly(ortho ester) designed for controlled drug delivery: validation and radiation effectsPharmaceutical research
accessLevelPublic
1994 103 114
In vitro and in vivo evaluation of progesterone implants based on new biodegradable poly(glutamic and glutamate esters) copolymersJournal of biomaterials science. Polymer ed
accessLevelRestricted
1994 175 0
Biocompatibility of a new semisolid bioerodible poly(ortho ester) intended for the ocular delivery of 5-fluorouracilJournal of biomedical materials research
accessLevelRestricted
1994 149 0
Application of Medical Imaging to Pharmaceutical Research: the Example of Gamma Scintigraphy. I: Technological AspectsEuropean journal of pharmaceutics and biopharmaceutics
accessLevelPublic
1994 184 19
Long-term histopathological study of new polypeptidic biomaterialsBiomaterials
accessLevelRestricted
1992 529 2
Preparation of aqueous polymeric nanodispersions by a reversible salting-out process: influence of process parameters on particle sizeInternational journal of pharmaceutics
accessLevelRestricted
1992 669 2
Aqueous nanodispersions prepared by a salting-out processInternational journal of pharmaceutics
accessLevelRestricted
1992 605 1
Du fard des Egyptiens aux pseudo-latex : évolution des formes médicamenteuses en ophtalmologieCahiers de la Faculté des sciences / Université de Genève
accessLevelPublic
1982 2 7
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack